Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
 
Join | Sign in
Home>Resources>Webcasts

  Webcasts

Scientific News
Potential Therapeutic for Blinding Eye Disease
NIH research points to microglia as potential therapeutic target in retinitis pigmentosa.
Potential New Class of Cancer Drugs
Scientists have found a way to stop cancer cell growth by targeting the Warburg Effect, a trait of cancer cell metabolism that scientists have been eager to exploit.
Global Search for Next Antibiotic
University of Queensland researchers have launched a global search to discover antibiotics capable of combating superbug bacteria that are resistant to current antibiotics.
New Clue to How Cancer Causes Organ Failure
New findings from a research group at Uppsala University show that the neutrophil, a type of blood cell, plays an important role in the process of induced organ failure.
Tackling Chemical Safety Rules and Regulations
Helsinki Chemicals Forum continues to lead international chemicals safety and management discussions.
Pioneering New Method to Map Enzyme Activity
Cardiff University researchers new discovery could have wide-reaching implications for the creation of manufactured goods, biofuels and therapeutic drugs.
Seashells to Deliver New Drugs and Vaccines
Australian scientists have developed a protective seashell-inspired capsule to preserve the active biological ingredients needed to create new drugs.
Euro Vision turns Reality for Australia’s Iconic ‘Green Whistle’
Patients will soon benefit from a unique invention, with emergency pain killer Penthrox receiving initial regulatory approval for sale in the European and UK markets.
New Type of Drug Can Target All Disease-causing Proteins
Current drugs block the actions of only about a quarter of known disease-causing proteins, but Yale University researchers have developed a technology capable of not just inhibiting, but destroying every protein it targets.
Laser Technique for Self-Assembly of Nanostructures
Researchers have developed a low-cost technique that holds promise for a range of scientific and technological applications.

Screening for Transient Drugs/Fragments: New Opportunities for Drug Discovery
Sten Ohlson, Professor, University of Kalmar, speaking at MedChem Europe 2009

Structural Insights into Antagonist-K+ Channel Interactions
Olaf Pongs, Professor, Hamberg University, Screening Europe 2009

Filling in the Gaps of Early Drug Discovery with High-Throughput Label-Free Biosensors: Hope, Hype or Truth?
Julio Jose Martin, Manager Screening and Compound Profiling, GlaxoSmithKline, Screening Europe 2009

A Structural View on Protein Kinase CK2 and its Potential Role as a Target for Small Molecules
Karsten Niefind, University of Cologne, speaking at Screening Europe 2009

Fragment Based Drug Discovery of Novel MK2 Inhibitors
Thomas Hesterkamp, VP Fragment Based Drug Discovery, Evotec AG, speaking at MedChem Europe 2009

Development of DIBENZOSUBERONES as Potent and Highly Selective p38 MAPK Inhibitors
Stefan Laufer, Professor, Department Head, Eberhard-Karls-University Tuebingen, speaking at MedChem Europe 2009

Impedance-Based Measurement of GPCR Modulators in Drug Discovery – Characterization of Signalling Pathways in Recombinant and Non-Recombinant Cells
John Gatfield, Senior Lab Head Molecular Biology, Actelion Pharmaceuticals Ltd, speaking at Screening Europe 2009

Advancing Drug Discovery in an Academic Setting
Julie Frearson, Professor Biotechnology/Drug Discovery/Biological Chemistry and Molecular Pharmacology, University of Dundee, speaking at Screening Europe 2009

De Novo Molecular Design: A Powerful Strategy for the Discovery of New Potential Antimalarials and Antibacterials
Colin Fishwick, Reader/ Director Organic Chemistry/Leeds Structure-Based Drug Design Group, University of Leeds School of Chemistry, speaking at MedChem Europe 2009

<< 7 8 9 10 11 12 13 >>
Showing Results 91 - 100 of 146
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters